NASDAQ
SRTS
Last Price
US $3.16
KEY FIGURES
MKT CAP
$52.0M
EPS
TTM
$-0.95
EPS Growth (1Y)
-214.63%
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
2.96x
YIELD
-
GROWTH (5Y CAGR)
Revenue
Valuation
Financial
Performance
Cash flow to debt coverage
Sensus Healthcare, Inc. cash flow to debt ratio of 77.65% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Free cash flow growth
Sensus Healthcare, Inc.'s free cash flow has increased -129.99% from $-1.11M last year to $332.00K, signaling increasing performance
Debt-to-equity ratio
Sensus Healthcare, Inc.'s debt to equity ratio is 0.01, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Sensus Healthcare, Inc.'s debt has decreased relative to shareholder equity from 0.01 last year to 0.01 today, signaling strengthened financials
Net debt to EBITDA
Sensus Healthcare, Inc. has a net cash position, so leverage is healthy.
Interest coverage
Sensus Healthcare, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.
Profit margin growth
Sensus Healthcare, Inc.'s profit margin has decreased (316.98%) in the last year from 15.90% to -34.50%, signaling decreasing performance
Current ratio
Sensus Healthcare, Inc.'s short-term assets of $45.89M exceed its short-term liabilities of $4.72M
Return on assets
Sensus Healthcare, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Sensus Healthcare, Inc.'s return on equity of -15.79%, is lower than 15.00%, indicating bad performance
Earnings quality
Sensus Healthcare, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Sensus Healthcare, Inc. had positive net income in 4 out of 5 years, indicating stable and consistent earnings
Positive free cash flow
Sensus Healthcare, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
Sensus Healthcare, Inc. has a free cash flow yield of 0.65%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Earnings growth
Sensus Healthcare, Inc.'s yearly earnings has decreased 216.13% since last year from $6.65M to $-7.72M, signaling decreasing performance
Revenue growth
Sensus Healthcare, Inc.'s yearly revenue has decreased 34.26% since last year from $41.81M to $27.48M, signaling decreasing performance
Return on invested capital
ROIC -17.84% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Sensus Healthcare, Inc.'s 3-year revenue CAGR of -14.86% is negative, indicating declining revenue over the past 3 years
Revenue consistency
Sensus Healthcare, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Sensus Healthcare, Inc. had positive ROE in 4 out of 5 years, indicating consistent and reliable returns on equity
Cash Flow Valuation (DCF)
Sensus Healthcare, Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Sensus Healthcare, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Sensus Healthcare, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Sensus Healthcare, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Sensus Healthcare, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Sensus Healthcare, Inc. has a price-to-book ratio of 1.12x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Sensus Healthcare, Inc. has a price-to-sales ratio of 2.26x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-31.46%
Return on equity
ROIC: -28.85%
Valuation History
-
Price to Earnings
EV/EBITDA: -3.6X
Cash flow
Profit margin
23.47%
EBITDA
-7.97%
Cash flow
-
Cash Flow (DCF)
Fair Value
Market $3.16
—
Default assumptions
EBITDA Multiple
Fair Value
Market $3.16
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.